Community lists
Selección · Salud

Lab tools & diagnostics

Por InspectStocksPublished 14 oct 202620 companies0 followers

Instruments, supplies and testing services for labs, drugmakers and doctors.

Agrupadas con ayuda de un modelo de IA y revisadas por nuestros editores. La línea bajo cada empresa explica por qué está aquí.

Los precios de las acciones son el cierre del 11 nov 2026, del feed de la bolsa IEX.

Grade mix

A 8B 8C 2D 1F 1

Revenue growing

19 of 20

Free cash flow growing

9 of 20

Median price move, 1 year

+22,0 %

  • TMOTHERMO FISHER SCIENTIFIC INC.

    Diagnostics and researchMarket cap 265,9B US$P/E 37,85

    717,62 US$+22,5 %1Y

    Since added +8,2 %

    A+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Acelerando
    Business quality
    Fuerte
    Getting better
    Mejorando

    Revenue

    47,4B US$+8,3 %

    Profit

    7,1B US$+7,6 %

    Free cash flow

    7,6B US$+24,3 %
    Why it is here: Sells lab instruments, reagents and services to researchers and drug makers
  • DHRDANAHER CORPORATION

    Diagnostics and researchMarket cap 165,5B US$P/E 38,51

    235,31 US$+8,0 %1Y

    Since added +5,4 %

    B+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Acelerando
    Business quality
    Fuerte
    Getting better
    Mejorando

    Revenue

    25,6B US$+5,5 %

    Profit

    4,3B US$+23,6 %

    Free cash flow

    5,7B US$+14,2 %
    Why it is here: Sells research instruments, supplies and services
  • AAGILENT TECHNOLOGIES, INC.

    Diagnostics and researchMarket cap 49,9B US$P/E 34,89

    176,91 US$+17,6 %1Y

    Since added +3,1 %

    B+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Acelerando
    Business quality
    Fuerte
    Getting better
    Mejorando

    Revenue

    7,4B US$+8,6 %

    Profit

    1,4B US$+18,0 %

    Free cash flow

    1,3B US$+16,5 %
    Why it is here: Sells lab instruments, consumables and software to labs and drug makers
  • WATWaters Corporation

    Diagnostics and researchMarket cap 46,3B US$P/E 202,08

    470,84 US$+21,5 %1Y

    Since added +9,7 %

    D
    Crecimiento y caja
    Creciendo
    Business trend
    Desacelerando
    Business quality
    Mixta
    Getting better
    Mixto

    Revenue

    5,6B US$+84,2 %

    Profit

    98,6M US$-84,8 %

    Free cash flow

    290,8M US$-51,7 %
    Why it is here: Sells liquid chromatography and mass spectrometry instruments and consumables
  • MTDMettler-Toledo International Inc.

    Diagnostics and researchMarket cap 34,8B US$P/E 37,95

    1749,30 US$+20,8 %1Y

    Since added +9,4 %

    B+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Fuerte
    Getting better
    Mejorando

    Revenue

    4,2B US$+6,5 %

    Profit

    934,1M US$+11,8 %

    Free cash flow

    870,6M US$-2,1 %
    Why it is here: Makes precision laboratory instruments and weighing equipment
  • ILMNIllumina, Inc.

    Diagnostics and researchMarket cap 32,2B US$P/E 36,64

    212,86 US$+74,5 %1Y

    Since added -21,5 %

    A+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Fuerte
    Getting better
    Mejorando con fuerza

    Revenue

    4,5B US$+5,8 %

    Profit

    895M US$+27,5 %

    Free cash flow

    1,1B US$+5,7 %
    Why it is here: Sells DNA sequencing instruments and reagents
  • IDXXIDEXX LABORATORIES INC /DE

    Diagnostics and researchMarket cap 55,4B US$P/E 47,37

    703,00 US$-1,5 %1Y

    Since added +35,2 %

    A+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Fuerte
    Getting better
    Mejorando con fuerza

    Revenue

    4,7B US$+11,9 %

    Profit

    1,2B US$+15,1 %

    Free cash flow

    1,3B US$+35,3 %
    Why it is here: Sells veterinary diagnostic tests and instruments
  • DGXQuest Diagnostics Inc

    Diagnostics and researchMarket cap 28,5B US$P/E 25,77

    258,72 US$+40,8 %1Y

    Since added +12,2 %

    A
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Sólida
    Getting better
    Mejorando

    Revenue

    11,8B US$+9,1 %

    Profit

    1,1B US$+16,5 %

    Free cash flow

    1,4B US$-1,3 %
    Why it is here: Provides diagnostic testing and clinical lab services
  • LHLABCORP HOLDINGS INC.

    Diagnostics and researchMarket cap 30,2B US$P/E 30,53

    372,18 US$+41,3 %1Y

    Since added +18,7 %

    A
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Mixta
    Getting better
    Mejorando con fuerza

    Revenue

    14,6B US$+6,0 %

    Profit

    1B US$+17,4 %

    Free cash flow

    1,3B US$-6,8 %
    Why it is here: Provides diagnostic tests and clinical lab services
  • RVTYREVVITY, INC

    Diagnostics and researchMarket cap 17,7B US$P/E 70,32

    158,22 US$+68,5 %1Y

    Since added +2,0 %

    A
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Mixta
    Getting better
    Mejorando

    Revenue

    2,9B US$+4,6 %

    Profit

    253,2M US$+6,6 %

    Free cash flow

    590,5M US$+18,7 %
    Why it is here: Sells lab instruments, reagents and diagnostics tools to research and drug makers
  • IQVIQVIA HOLDINGS INC.

    Diagnostics and researchMarket cap 45,2B US$P/E 33,38

    274,37 US$+24,2 %1Y

    Since added +5,2 %

    A
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Mixta
    Getting better
    Mejorando

    Revenue

    17,3B US$+8,8 %

    Profit

    1,4B US$+8,7 %

    Free cash flow

    2,1B US$-6,0 %
    Why it is here: Runs clinical trials and sells healthcare data to drugmakers
  • NTRANATERA, INC.

    Diagnostics and researchMarket cap 46,4B US$Sin PER (pérdida operativa)

    319,77 US$+52,6 %1Y

    Since added -19,2 %

    B-
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Débil
    Getting better
    Mixto

    Revenue

    2,9B US$+37,4 %

    Profit

    -164,7M US$+46,7 %

    Free cash flow

    52,5M US$-50,5 %
    Why it is here: Provides genetic and cell-free DNA diagnostic tests
  • TECHBIO-TECHNE Corp

    BiotechnologyMarket cap 11,4B US$P/E 66,77

    72,78 US$+19,2 %1Y

    Since added +0,4 %

    A+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Acelerando
    Business quality
    Fuerte
    Getting better
    Mejorando con fuerza

    Revenue

    1,2B US$+0,9 %

    Profit

    172M US$+120,5 %

    Free cash flow

    308,2M US$+37,6 %
    Why it is here: Sells proteins, antibodies and diagnostic reagents to researchers
  • BRKRBRUKER CORPORATION

    Medical devicesMarket cap 9,5B US$Sin PER (pérdida operativa)

    62,41 US$+47,5 %1Y

    Since added +11,0 %

    B
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Desacelerando
    Business quality
    Mixta
    Getting better
    Mixto

    Revenue

    3,5B US$+2,2 %

    Profit

    -123,4M US$-490,4 %

    Free cash flow

    244,7M US$+2408,5 %
    Why it is here: Makes scientific instruments for microscopy, spectroscopy and magnetic resonance research
  • RGENREPLIGEN CORP

    Medical instruments and suppliesMarket cap 9,8B US$No P/E

    172,68 US$+9,3 %1Y

    Since added -1,6 %

    B
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Desacelerando
    Business quality
    Mixta
    Getting better
    Mejorando

    Revenue

    805,6M US$+13,8 %

    Profit

    -11,8M US$-779,2 %

    Free cash flow

    106,7M US$-3,0 %
    Why it is here: Supplies bioprocessing filtration, chromatography and protein products to biologic drug makers
  • BIOBIO-RAD LABORATORIES, INC.

    Medical devicesMarket cap 10,4B US$Sin PER (pérdida operativa)

    386,08 US$+18,0 %1Y

    Since added +6,1 %

    C
    Crecimiento y caja
    Creciendo
    Business trend
    Estable
    Business quality
    Sólida
    Getting better
    Mejorando

    Revenue

    2,6B US$+1,4 %

    Profit

    1B US$+251,3 %

    Free cash flow

    329,1M US$-2,3 %
    Why it is here: Sells life science research tools and clinical diagnostics reagents and instruments
  • QGENQIAGEN N.V.

    Diagnostics and researchMarket cap 10,9B US$P/E 25,93

    50,30 US$+19,8 %1Y

    Since added +10,7 %

    B+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Fuerte
    Getting better
    Mejorando

    Revenue

    2,1B US$+2,1 %

    Profit

    384,5M US$-5,2 %

    Free cash flow

    436,2M US$-8,9 %
    Why it is here: Supplies sample preparation and molecular testing kits and instruments
  • GHGUARDANT HEALTH, INC.

    Diagnostics and researchMarket cap 20,9B US$Sin PER (pérdida operativa)

    154,76 US$+58,2 %1Y

    Since added -4,5 %

    B
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Estable
    Business quality
    Mixta
    Getting better
    Mixto

    Revenue

    1,3B US$+41,7 %

    Profit

    -485,1M US$-21,6 %

    Free cash flow

    -232,1M US$+11,5 %
    Why it is here: Provides blood-based cancer diagnostic tests
  • MEDPMedpace Holdings, Inc.

    Diagnostics and researchMarket cap 18,6B US$P/E 36,90

    664,52 US$+11,2 %1Y

    Since added +9,0 %

    C+
    Crecimiento y caja
    Creciendo con fuerza
    Business trend
    Desacelerando
    Business quality
    Fuerte
    Getting better
    Mejorando con fuerza

    Revenue

    2,8B US$+20,4 %

    Profit

    517,8M US$+19,6 %

    Free cash flow

    667,6M US$-1,4 %
    Why it is here: Runs clinical trials for biotech and pharma drug developers
  • CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.

    Diagnostics and researchMarket cap 16,4B US$P/E 353,20

    342,61 US$+99,8 %1Y

    Since added +14,5 %

    F
    Crecimiento y caja
    Mixto
    Business trend
    Contrayéndose
    Business quality
    Mixta
    Getting better
    Mixto

    Revenue

    4B US$-1,2 %

    Profit

    40,2M US$+148,8 %

    Free cash flow

    399,6M US$-26,5 %
    Why it is here: Provides preclinical research models and testing services to drug developers

Green and red compare each figure with the same window a year earlier. Grades and checks are the company page's own; nothing here is a recommendation.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.